Last updated 2026-06-18
- Raised $2.1M funding round led by Peregrine Ventures, Jul 2023
- Raised $2.9M grant led by BIRD Foundation, Jan 2023
- Raised funding round led by Peregrine Ventures, Feb 2025
Total raised
$5.0M
Last: 2025-02
Stage
Seed
Founded
2019
Headcount
2
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Xerient is focused on unmet needs in cancer treatment, particularly in abdominal and gastrointestinal cancers. Xerient is pursuing the development of novel therapeutics and diagnostic technologies that can dramatically improve the survival of these patients.
The company is introducing a portfolio of products that will address hard to treat cancers in the abdominal/GI area, beginning with solutions for pancreatic cancer.
Funding history · 3 rounds · $5.0M total
2025-02
Undisclosed
2023-07
2023-01
Grant
$2.9M
Q&A
- What is Xerient's primary focus?
- Xerient is focused on developing novel therapeutics and diagnostic technologies for unmet needs in cancer treatment, particularly in abdominal and gastrointestinal cancers, starting with solutions for pancreatic cancer.
- When was Xerient founded?
- Xerient was founded in May 2019.
- What is Xerient's current funding stage?
- Xerient is currently in the Seed funding stage.
- What was Xerient's most recent funding activity?
- In February 2025, Xerient had a funding round with Peregrine Ventures as a lead investor.
- Which investors participated in Xerient's July 2023 funding round?
- In July 2023, Xerient received funding from Peregrine Ventures and SIBF VC.
- Has Xerient received any grants?
- Yes, in January 2023, Xerient received a grant of $2,930,000 from the BIRD Foundation.
- Who is the Co-founder and CEO of Xerient?
- Guy Yachin is the Co-founder and CEO of Xerient.
- Does Xerient hold any patents?
- Yes, Xerient holds one patent.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
gastroenterologycancerpharmaceuticalscancer-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | xerient.net/ |
|---|---|
| linkedin.com/company/56424827 |
Identifiers & details
| Founded | 2019-5 |
|---|---|
| Employees (exact) | 2 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | xerient.net |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|